Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome.
Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Cavero T, Fernandez-Cusicanqui J, Blasco M, Cabello V, Calvo N, Diaz M, Herrero-Goñi M, Aguirre M, Elías S, Alcaide MP, Ramos N, Sellares J, Rodríguez de Córdoba S. Huerta A, et al. Among authors: portoles j. Kidney Int. 2023 Oct;104(4):851-855. doi: 10.1016/j.kint.2023.07.020. Epub 2023 Aug 9. Kidney Int. 2023. PMID: 37567446 Free article. No abstract available.
[Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: Renal replacement therapy and mortality. FRA-COVID SEN Registry Data].
Salgueira M, Almenara M, Gutierrez-Pizarraya A, Belmar L, Labrador PJ, Melero R, Serrano ML, Portolés JM, Molina A, Poch E, Ramos N, Lloret MJ, Echarri R, Díaz Mancebo R, González-Lara DM, Sánchez JE, Soler MJ. Salgueira M, et al. Nefrologia. 2023 Apr 6. doi: 10.1016/j.nefro.2023.03.008. Online ahead of print. Nefrologia. 2023. PMID: 37359780 Free PMC article. Spanish.
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration.
de Sequera P, Pérez-García R, Vega A, Martínez-Vaquera S, Acosta JG, Pérez Del Valle K, Fernández-Lucas M, García-Rubiales MA, García-Herrera AL, Coll E, Mérida E, Martínez-Miguel P, Castaño I, Gil-Casares B, Garro J, Maduell F; MOTheR collaborative network. de Sequera P, et al. Clin Kidney J. 2023 May 27;16(11):2254-2261. doi: 10.1093/ckj/sfad128. eCollection 2023 Nov. Clin Kidney J. 2023. PMID: 37915938 Free PMC article.
Prevalence and severity of pruritus in Spanish patients with chronic kidney disease and impact on quality of life: a cross-sectional study.
Aresté N, Sanchez-Alvarez JE, Prieto-Velasco M, Molina P, Esteve-Simó V, Ojeda R, Buades JM, Goicoechea M, Sanchez-Villanueva R, Bezhold GA, Pérez-Morales RE, Santos AB, Peiró-Jordan R, Arenas MD; Pruritus Week Group. Aresté N, et al. Clin Kidney J. 2023 Mar 23;16(6):1035-1037. doi: 10.1093/ckj/sfac246. eCollection 2023 Jun. Clin Kidney J. 2023. PMID: 37260996 Free PMC article. No abstract available.
Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language Processing.
Ortiz A, Portoles J, Pino-Pino MD, Barea J, López M, de Sequera P, Quiroga B, Echarri R, Prieto Velasco M, Díaz R, Gómez Marqués G, Sanchez Perez P, Torregrosa V, Rodriguez M; SAVANA Research Group,; SENEFRO-BD-SHPT working group. Ortiz A, et al. Among authors: portoles j. Kidney Dis (Basel). 2023 Jan 23;9(3):187-196. doi: 10.1159/000528784. eCollection 2023 May. Kidney Dis (Basel). 2023. PMID: 37497203 Free PMC article.
Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry.
López-Oliva MO, Pérez-Flores I, Molina M, José Aladrén M, Trujillo H, Redondo-Pachón D, López V, Facundo C, Villanego F, Rodríguez M, Carmen Ruiz M, Antón P, Rivas-Oural A, Cabello S, Portolés J, de la Vara L, Tabernero G, Valero R, Galeano C, Moral E, Ventura A, Coca A, Ángel Muñoz M, Hernández-Gallego R, Shabaka A, Ledesma G, Bouarich H, Ángeles Rodríguez M, Pérez Tamajón L, Cruzado L, Emilio Sánchez J, Jiménez C. López-Oliva MO, et al. Among authors: portoles j. Nefrologia (Engl Ed). 2023 Jul-Aug;43(4):442-451. doi: 10.1016/j.nefroe.2023.08.004. Epub 2023 Sep 1. Nefrologia (Engl Ed). 2023. PMID: 37661514 Free article.
Reticulocyte hemoglobin content and iron therapy in chronic kidney disease: Reply of the Anemia group of the Spanish Society of Nephrology.
Cases A, de Sequera P, Quiroga B, Puchades MJ, Martin-Rodriguez L, Gorriz JL, Portolés J; en representación del Grupo de Anemia de la S.E.N.. Cases A, et al. Among authors: portoles j. Nefrologia (Engl Ed). 2023 Sep-Oct;43(5):651-652. doi: 10.1016/j.nefroe.2021.06.012. Epub 2023 Nov 6. Nefrologia (Engl Ed). 2023. PMID: 37940479 Free article. No abstract available.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
150 results